An informal yet insightful commentary featuring interviews and perspectives from leaders in vitreoretinal surgery as well as the next generation of retinal specialists
Drs. Priya Vakharia and Sarwar Zahid join to discuss their favorite discussions from AAO 2025, including geographic atrophy, pipeline products, practice consolidation, and whole eye transplantation.
Drs. Akshay Thomas and Sarwar Zahid join for a journal club episode discussion of three recent publications:
Fellow Eye PVD (https://journals.sagepub.com/doi/full/10.1177/24741264251379842)
Syfovre versus Izervay (https://journals.sagepub.com/doi/full/10.1177/24741264251379842)
Litigation Involving Intravitreal Injections (https://www.ophthalmologyretina.org/article/S2468-6530(25)00439-7/abstract)
Disclosures: Dr. Sridhar has consulted for Apellis and Astellas in the past 3 years.
Drs. Kat Talcott and Sarwar Zahid join to discuss the December 2025 edition of Retinal Physician, including an overview of TKIs for retinal disease, the fluorinated gas and sustainability question, best practices for research clinical trial sites, and fellowship selection advice.
In this extra 'bonus' fourth episode for October 2025 Drs. Albert Lin and Jay Sridhar conduct a medical/surgical retina Q+A session at the University of Mississippi.
Drs. Priya Vakharia and Sarwar Zahid join for a journal club discussion.
Functional Benefit in Geographic Atrophy Treatment (https://jamanetwork.com/journals/jamaophthalmology/fullarticle/2839343)
GLP-1 Agonists and Uveitis (https://jamanetwork.com/journals/jamaophthalmology/article-abstract/2838119)
Metformin and AMD (https://jamanetwork.com/journals/jamaophthalmology/article-abstract/2838821)
Drs. Kat Talcott, Akshay Thomas, and Sarwar Zahid join for this very special crossover "Retflix and Chill" episode recorded live at ASRS 2025 including discussion of the current state of retina practice management and economics.
Drs. Marianeli Rodriguez and Kat Talcott join to discuss the October 2025 edition of Retinal Physician, including inherited retinal disease treatment pipeline, gene therapy, and systemic therapy for sickle cell disease and retinopathy.
Drs. Sarwar Zahid and Safa Rahmani join for a journal club discussion of the following articles:
Cannabis Use and PVR Risk (https://jamanetwork.com/journals/jamaophthalmology/article-abstract/2835775)
Neovascular AMD Presentation (https://www.aaojournal.org/article/S0161-6420(25)00458-0/abstract)
Macular Hole Closure Without Gas (https://www.ophthalmologyretina.org/article/S2468-6530(25)00276-3/abstract)
OKAPS Score and Board Exam Results (https://jamanetwork.com/journals/jamaophthalmology/article-abstract/2835951)
Drs. Akshay Thomas and Sarwar Zahid join to discuss the September 2025 edition of Retinal Physician, including port delivery system thoughts, AI for ROP, and suprachoroidal injections.
Drs. Steve Christiansen, Alex Ringeisen, and Sarwar Zahid rejoin the program to discuss updates to their experiences in solo retina practice.
Drs. Zubair Ansari and Basil Williams join for a candid discussion regarding the state of the ophthalmology residency match, including a discussion of dropping match percentages and the introduction of preference signaling.